Mapping The Corporate Genome
New white paper on the global Legal Entity Identifier (LEI) initiative
Thomson Reuters is committed to mapping the "corporate genome" and promoting the evolution of legal entity data for the benefit of forward-looking institutions looking for innovation in risk management and an edge in the marketplace.
A primary aim of the global Legal Entity Identifier (LEI) initiative is to provide market participants with the ability to use a common set of reference data to easily identify legal entities and their associated inter-connections (parent, subsidiary and affiliate) - across multiple platforms/repositories (trading, data, compliance).
Equally, by using LEIs market participants will be able to map those entities back to their associated securities/debt issues thus allowing market players to efficiently correlate their risk exposure to a counterparty at any given moment in time.
In light of this complex market challenge we have published a detailed white paper Legal Entity Data: Mapping The Corporate Genome that provides:
- an overview of where the LEI initiative now stands and its associated background
- a comprehensive understanding of what the operational and systems impact of using Legal Entity Data will be
- an outline of what additional beneficial outcomes market participants can expect from using Legal Entity Data and
- a better understanding of Thomson Reuters perspective with regard to the LEI initiative and the need for Legal Entity Data